Breathe Well Live Well
|
Respiratory Devices Market: Rising Incidences of COPD and Asthma Fuelling Demand
Medgadget.com (blog) Future-Market-Insights57 Future Market Insights has announced the addition of the “Respiratory Devices Market: Global Industry Analysis and Opportunity Assessment 2015-2025” report to their offering. Respiratory devices are medical devices that are … |
View full post on asthma – Google News
|
Global Market Research of Asthma and COPD Drug Market : An In-Depth Analysis …
Medgadget.com (blog) According to a recent market study published by Transparency Market Research (TMR), Everyone wants to breathe the air of freedom without any major hindrance or respiratory problem. However, in many cases, people suffer from breathing problems that … |
View full post on asthma – Google News
|
Asthma Therapeutics Sales Global Market Research Report 2015
Medgadget.com (blog) The Global Asthma Therapeutics Sales 2015 Market Research Report is a professional and in-depth study on the current state of the Asthma Therapeutics market. The report provides a basic overview of the Asthma Therapeutics industry including definitions … |
View full post on asthma – Google News
Market Realist |
FDA Will Review Teva's BLA for Asthma Drug Reslizumab
Market Realist Interleukin-5 is a key cytokine involved in the maturation, recruitment, and activation of eosinophils, which are inflammatory white blood cells implicated in a number of diseases, such as asthma. Elevated levels of blood eosinophils are a risk factor … |
View full post on asthma – Google News
|
Nebulizers, Inhalers and Respirators for Asthma Treatment Market: PMR's …
Medgadget.com (blog) logo346 Asthma is a chronic inflammatory lung disease which affects persons across all ages. It creates inflammation inside the walls of airways, causing airways to narrow, swell and produce extra mucous. It is caused due to genetic factors or … |
View full post on asthma – Google News
|
Asthma and COPD Drug Market expected to reach USD 26965.5 million in 2017
Medgadget.com (blog) According to a recent market study published by Transparency Market Research (TMR), the global asthma and COPD market was worth USD 25,102.3 million in 2010, which is expected to reach USD 26,965.5 million in 2017 along with a CAGR figure of … |
View full post on asthma – Google News
ETHealthWorld.com |
Ajanta Pharma launches generic asthma drug in US market
ETHealthWorld.com New Delhi, Nov 16 : Ajanta Pharma today said it has launched generic version of Singulair granules, used in the treatment of asthma, in the US market. The company in a filing to BSE said Ajanta Pharma US Inc has launched montelucast sodium granules, … Ajanta Pharma launches generic asthma drug in US market; shares up over 2% |
View full post on asthma – Google News
|
Ajanta Pharma Launches Generic Asthma Drug in US Market
NDTV New Delhi: Ajanta Pharma on Monday said it has launched generic version of Singulair granules, used in the treatment of asthma, in the US market. The company in a filing to BSE said Ajanta Pharma US Inc has launched montelucast sodium granules, … |
View full post on asthma – Google News
|
Global COPD and Asthma Devices Market Industry Analysis 2015-2019 with Consort …
PR Newswire (press release) The global COPD and asthma devices market to grow at a CAGR of 3.76% over the period 2014-2019. The report, Global COPD and Asthma Devices Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry … FMI: Respiratory Measurement Devices Market Segments, Opportunity, Growth and … |
View full post on asthma – Google News
|
Global COPD and Asthma Devices Market – Industry Analysis 2015-2019
PR Newswire (press release) COPD and asthma devices are used for inhalation therapy. These devices convert drug suspensions or solutions into aerosolized particles, assisting in drug delivery in individuals with breathing problems. These devices deliver an optimum dosage of … |
View full post on asthma – Google News